Xiaodong Tang

6PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsOral and maxillofacial surgeryPredictive and prognostic markersMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 25, 2025
Apatinib plus ifosfamide and etoposide versus ifosfamide and etoposide in patients with advanced osteosarcomas (OAIE/PKUPH-sarcoma 11): a randomized phase II study.

Lu Xie, Jie Xu, Xin Sun

|Jul 20, 2024
Efficacy and Safety of Fruquintinib-Based Treatment in Patients with Refractory Bone and Soft Tissue Sarcoma after Developing Resistance to Several TKIs: A Multicenter Retrospective Study.

Chenchen Yang, Binghao Li, Sen Dong

|Jun 11, 2024
Intentional Dural Resection during en bloc Spinal Resection Could Provide a Secure Surgical Margin for Patients with Recurrent Spinal Tumors.

Zhiye Du, Xiaodong Tang, Zhenyu Cai

|Jan 09, 2023
Longer versus Shorter Schedules of Vincristine, Irinotecan, and Temozolomide (VIT) for Relapsed or Refractory Ewing Sarcoma: A Randomized Controlled Phase 2 Trial.

Jie Xu, Lu Xie, Xin Sun

|Nov 14, 2022
Circulating Exosomal PD-L1 at Initial Diagnosis Predicts Outcome and Survival of Patients with Osteosarcoma.

Jun Wang, Wei Guo, Xiaofang Wang

|May 20, 2020
3D-Printed Modular Hemipelvic Endoprosthetic Reconstruction Following Periacetabular Tumor Resection: Early Results of 80 Consecutive Cases.

Tao Ji, Yi Yang, Xiaodong Tang

Pageof 1

Frequent Collaborators

3 joint publications

Tao Ji

3 joint publications

Wei Guo

2 joint publications

Xin Sun

1 joint publications

Yi Yang